🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Can we use synthetic data to smooth getting new treatments to people? Come find out REDDIEdiabetes

Your yearly reminder that “We need less research, better research, and research done for the right reasons” #OTD 1948 Douglas Altman b (d 3 June 2018)🇬🇧 A brilliant statistics educator & “one of the most influential medical statisticians of the past 50 years” /5

Please join us for the 🔥hot 🔥topic of synthetic data with its potential to assess clinical and cost effectiveness faster, if not also better. RDM Oxford The University of Edinburgh The University of Manchester University of Warwick NICE University of Liverpool MHRAgovuk Novo Nordisk Università di Padova Horizon Europe 🇪🇺 and others

🧐Job opening at #REDDIE University of Leicester is looking for a Research Associate in Statistics. The position is open within the 🌱Leicester Diabetes and is led by Pratik Choudhary. Check out the job position via the link or share it with someone who might be interested. 👉 bit.ly/3YjbZNU

Finally! 4 years after scientific fraud & politicised science derailed it, #COPCOV, the world’s largest COVID-19 chemoprevention study, published results today in PLOS Medicine: Hydroxychloroquine (HCQ) does have a moderate benefit in preventing #COVID-19 bit.ly/3XGdeGl

Missed our first #REDDIE webinar on synthetic data for regulatory and payer purposes? Read about it in the article and watch the full session from the keynote speaker, Prof. Gillian Raab. 👇 reddie-diabetes.eu/news/synthetic… #SyntheticData #Webinar #RWD #HorizonEU

Metformin in prostate cancer in a controlled trial with overall survival as the endpoint, and with metabolic secondary endpoints.

New Global Health Economics Centre + Anirban Basu + Amanda I Adler + Karla DO paper on HEC Editors! We used target trial emulation with local #IVs to examine treatment effect heterogeneity across subpopulations eligible and ineligible for a published RCT onlinelibrary.wiley.com/doi/10.1002/he…

This is a worry. How can we make clinical academic training more attractive? National Institute for Health and Care Research

NEW RESEARCH: Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population Read more 👇 shorturl.at/IPpib Amanda I Adler Medical Sciences #researchnews #diabetesnews

People with 'young-onset' (antibody negative) type 2 diabetes have higher rates of complications including dying when attaining the same age as people diagnosed later; a call to further the evidence for preventing or delaying type 2 diabetes in young people.

Today´s afternoon movie is "Coco" /2017/ The concept for Coco is inspired by the Mexican holiday Day of the Dead.

Halloween fun

For some treatments, NICE assesses effectiveness with ‘cure models’. Do ‘double cures’ offer twice the value? Nick Latimer Doctor Megan John

Just dropped - target trial emulation study on nationwide Scottish data showing better outcomes in patients who continued metformin after reaching CKD stage 4 - by Samira Bell et al. Am J Kidney Disease ajkd.org/article/S0272-…

Impressive goings-on in HTA in Asia presented at an impressively organized meeting. A model for meetings on modelling. Health Economics Research Centre (HERC) CUHK Medicine HITAP RDM Oxford

Still time to discuss/ apply for this clinical trials PhD opportunity in Glasgow!

Now data on metformin benefits and hearing loss! Metformin use is associated with a dose-dependent reduction in hearing loss risk and lower mortality in people with T2 diabetes! Metformin keep giving! dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

We just hosted the second progress meeting of the Horizon Europe REDDIEdiabetes project at our department! Two days of discussions, workshops, and collaboration with our international partners—plus great food and spring vibes in Padua! 😊 #HorizonEurope #REDDIEDiabetes #UniPD

Great group of students- lotsa fun!